Paytm IPO vs Tatva Chintan Pharma IPO

Comparision between Paytm IPO and Tatva Chintan Pharma IPO.

IPO Details

Paytm IPO is a Mainline Book Built Issue IPO proposed to list at BSE, NSE while Tatva Chintan Pharma IPO is a Mainline Book Built Issue proposed to list at BSE, NSE.

	Paytm IPO	Tatva Chintan Pharma IPO
Logo
Issue Category	Mainline	Mainline
Issue Type	IPO	IPO
Process Type	Book Built Issue	Book Built Issue
Listing At	BSE, NSE	BSE, NSE
Lead Managers	Axis Capital Limited Citigroup Global Markets India Private Limited Goldman Sachs (India) Securities Private Limited Hdfc Bank Limited ICICI Securities Limited J.P. Morgan India Private Limited Morgan Stanley India Company Pvt Ltd	ICICI Securities Limited Jm Financial Limited
Registrar	Link Intime India Private Ltd	Link Intime India Private Ltd
Market Maker
DRHP	DRHP	DRHP
RHP	RHP	RHP
Anchor Investor
IPO Allotment URL	IPO Allotment URL	IPO Allotment URL

Issue Size and Price

The total issue size of Paytm IPO is up to ₹18,300.00 Cr whereas the issue size of the Tatva Chintan Pharma IPO is up to ₹500.00 Cr. The final issue price of Paytm IPO is ₹2,150.00 per share and of Tatva Chintan Pharma IPO is ₹1,083.00 per share.

	Paytm IPO	Tatva Chintan Pharma IPO
Face Value	₹1 per share	₹10 per share
Issue Price (Lower)	₹2,080.00 per share	₹1,073.00 per share
Issue Price (Upper)	₹2,150.00 per share	₹1,083.00 per share
Issue Price (Final)	₹2,150.00 per share	₹1,083.00 per share
Discount (Retail)
Discount (Employee)
Market Lot Size	6 shares	13 shares
Fresh Issue Size
Fresh Issue Size (Amount)	up to ₹8,300.00 Cr	up to ₹225.00 Cr
OFS Issue Size
OFS Issue Size (Amount)	up to ₹10,000.00 Cr	up to ₹275.00 Cr
Issue Size Total
Issue Size Total (Amount)	up to ₹18,300.00 Cr	up to ₹500.00 Cr

IPO Timetable

Paytm IPO opens on Nov 08, 2021, while Tatva Chintan Pharma IPO opens on Jul 16, 2021. The closing date of Paytm IPO and Tatva Chintan Pharma IPO is Nov 10, 2021, and Jul 20, 2021, respectively.

	Paytm IPO	Tatva Chintan Pharma IPO
Anchor Bid Date
Issue Open	Nov 08, 2021	Jul 16, 2021
Issue Close	Nov 10, 2021	Jul 20, 2021
Basis Of Allotment (Tentative)	Nov 15, 2021	Jul 26, 2021
Initiation of Refunds (Tentative)	Nov 16, 2021	Jul 27, 2021
Credit of Share (Tentative)	Nov 17, 2021	Jul 28, 2021
Listing date (Tentative)	Nov 18, 2021	Jul 29, 2021
Anchor Lockin End date 1	Dec 15, 2021	Aug 25, 2021
Anchor Lockin End date 2	Feb 13, 2022	Oct 24, 2021

Financials

Paytm IPO P/E ratio is , as compared to Tatva Chintan Pharma IPO P/E ratio of .

Paytm IPO

Tatva Chintan Pharma IPO

Financial

Summary of financial Information (Restated Consolidated)
Particulars	For the year/period ended (₹ in million)
	30-Jun-21	30-Jun-20	31-Mar-21	31-Mar-20	31-Mar-19
Total Assets	94,590	102,777	91,513	103,031	87,668
Total Revenue	9,480	6,494	31,868	35,407	35,797
Profit After Tax	(3,819)	(2,844)	(17,010)	(29,424)	(42,309)

Summary of financial Information (Restated Consolidated)
Particulars	For the year/period ended (₹ in million)
	31-Mar-21	31-Mar-20	31-Mar-19
Total Assets	3,148.03	2,489.38	1,875.08
Total Revenue	3,062.92	2,646.22	2,068.01
Profit After Tax	522.62	377.89	205.43

Promoter Shareholding (Pre-Issue)

100%

Promoter Shareholding (Post-Issue)

79.17%

P/E Ratio

Market Cap

ROE

ROCE

Debt/Equity

EPS

RoNW

Shares Offered

In the Paytm IPO retail investors (RII) are offered 87,98,076 shares while in Tatva Chintan Pharma IPO retail investors are offered 87,98,076 shares. Qualified institutional buyers (QIB) are offered 2,63,94,231 shares in Paytm IPO and 9,31,966 shares in Tatva Chintan Pharma IPO.

	Paytm IPO	Tatva Chintan Pharma IPO
Anchor Investor Reserveration
Market Maker Reserveration
QIB	2,63,94,231 shares	9,31,966 shares
NII	1,31,97,115 shares	6,98,975 shares
RII	87,98,076 shares	16,30,941 shares
Employee	0 shares	0 shares
Others
Total	4,83,89,422 shares	32,61,882 shares

Bids Received (Subscription)

Paytm IPO subscribed 1.89x in total, whereas Tatva Chintan Pharma IPO subscribed 180.36x.

	Paytm IPO	Tatva Chintan Pharma IPO
QIB (times)	2.79x	185.23x
NII (times)	0.24x	512.22x
Big NII (times)
Small NII (times)
RII (times)	1.66x	35.35x
Employee (times)
Other (times)
Total (times)	1.89x	180.36x

Compare with others

Paytm IPO	Tatva Chintan Pharma IPO
Devyani International IPO	Windlas Biotech IPO
Windlas Biotech IPO	Exxaro Tiles IPO
Exxaro Tiles IPO	Nuvoco IPO
Nuvoco IPO	Rolex Rings IPO
Rolex Rings IPO	Paytm IPO
Tatva Chintan Pharma IPO	Zomato IPO
Zomato IPO	Glenmark Life Sciences IPO
Glenmark Life Sciences IPO	Clean Science IPO
Clean Science IPO	G R Infraprojects IPO
G R Infraprojects IPO	India Pesticides IPO

Comments

Add a public comment...